https://www.pharmtech.com/view/european-commission-issues-approval-pfizer-s-vyndaqel
European Commission Issues Approval of Pfizer’s Vyndaqel | Pharmaceutical Technology
Oct 14, 2026 - The European Commission (EC) has approved Pfizer’s treatment for wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy...
european commissionpharmaceutical technologyissuesapprovalvyndaqel